Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Solid Tumor · Colorectal Cancer · Non-small Cell Lung Cancer · Pancreatic Ductal Adenocarcinoma · Head and Neck Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin Municipality, China
Contact: Study coordinator (Jihui Hao) · haojihui@tjmuch.com · 18622221120
Contact: Principal Investigator (Yi Hu)
Contact: Principal Investigator (Jihui Hao)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Solid Tumor · Non-Small-Cell Lung Cancer · Pancreatic Ductal Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1

Santa Monica, United States · Atlanta, United States

Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

Advanced Solid Tumor · Metastatic Solid Tumor · Refractory Solid Tumor

Abroad (travel likely)RecruitingPHASE1

Sarasota, United States · Boston, United States

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Cancer · Tumor, Solid · Malignant Neoplasm

Abroad (travel likely)RecruitingPHASE1, PHASE2

Austin, United States · Irving, United States

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors · Triple Negative Breast Cancer (TNBC) · HR+ Breast Cancer

Abroad (travel likely)RecruitingPHASE1

Denver, United States · Houston, United States